Abstract
Summary
The pipette calibrators market is projected to reach USD 391 million by 2029 from USD 286 million in 2024, at a CAGR of 6.5% during the forecast period. The growth of this market is majorly driven by rise in automation and pharmaceutical & biotechnology industry expansion globally. However, presence of alternative methods and premium pricing could restrain the growth of the pipette calibrators market.
“Devices segment accounted for the highest market share in the pipette calibrators market, by type, during the forecast period.”
Based on type, the pipette calibrators market is classified into devices and software. The devices segment dominated the market in 2022. This segment is estimated to account for the highest CAGR during the forecast period. The large share of the segment can be attributed to the easy accessibility and are less labor-intesive devices.
“Single channel segment accounted for the highest market share in the pipette calibrators market, by channel type, during the forecast period.”
Based on channel type, the pipette calibrators market is classified into single channel and multi channel. The single channel segment dominated the market in 2022. This segment is estimated to account for the highest CAGR during the forecast period. The large share of the segment can be attributed to the higher usage of single channel pipettes in every area of the research and diagnostics.
“Research accounted for the highest CAGR during the forecast period.”
Based on the application, the pipette calibrators market is segmented clinical diagnostics and research. The research segment accounted for the highest CAGR of pipette calibrators market in 2022. The highest CAGR of this segment can be primarily attributed to the growth in research facilities across the globe promoted by the pharmaceutical & biotechnology and government investments.
“The North America segment accounted for the highest market share in the pipette calibrators market, by region, during the forecast period.”
Based on the region segmentation, the pipette calibrators market is divided into North America, Europe, Asia Pacific, and Rest of the World. During the forecast period the North America is expected to witness a larger market share. The availability of technologically advanced pipette calibrators and the increasing R&D spends by the phamra companies and government for the research activitues are supporting the growth of the pipette calibrators market.
Breakdown of supply-side primary interviews by company type, designation, and region:
• By Company Type: Tier 1 (30%), Tier 2 (48%), and Tier 3 (22%)
• By Designation: C-level (28%), Director-level (33%), and Others (39%)
• By Region: North America (21%), Asia- Pacific (34%), Europe (30%), and RoW (15%)
Prominent companies include METTLER TOLEDO (US), Sartorius AG (Germany), Advanced Instruments (US), A&D Company, Limited (Japan), Accuris Instruments (US), IKA Works GmbH & Co. KG (Germany), RADWAG Balances and Scales (Poland), Avantor, Inc. (US), Biohit Oyj (Finland), Calibration Lab (Belgium), BRAND GMBH + CO KG (Germany), Prime Technologies (US), BioMedical Computing Ltd. (UK), Cole-Parmer Instrument Company, LLC (US), Humpage Technology Ltd. (UK), IBR Inc. (Switzerland), Sartorius Croatia (Croatia), Gilson Incorporated (US), Labtronics Inc. (Canada), and Techvolver ApS (Denmark).
Research Coverage
This research report categorizes the pipette calibrators market by type, channel type, method, application, end user, and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the pipette calibrators market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, services; key strategies; Contracts, partnerships, and agreements. New product launches, mergers and acquisitions, and recent developments associated with the pipette calibrators market. Competitive analysis of upcoming startups in the pipette calibrators market ecosystem is covered in this report.
Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall pipette calibrators market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
• Analysis of key drivers, restraints, opportunities, and challenges influencing the growth of the pipette calibrators market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the pipette calibrators market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the pipette calibrators market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the pipette calibrators market
• Competitive Assessment: In-depth assessment of market ranking, growth strategies, and service offerings of leading players like METTLER TOLEDO (US), Sartorius AG (Germany), Advanced Instruments (US), A&D Company, Limited (Japan), among others in the pipette calibrators market strategies.
Table of Contents
1 INTRODUCTION 33
1.1 STUDY OBJECTIVES 33
1.2 MARKET DEFINITION 33
1.2.1 INCLUSIONS & EXCLUSIONS OF STUDY 34
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
1.3.2 REGIONS COVERED 35
1.3.3 YEARS CONSIDERED 35
1.4 CURRENCY 36
1.5 STAKEHOLDERS 36
1.6 LIMITATIONS 36
1.7 RECESSION IMPACT 36
2 RESEARCH METHODOLOGY 37
2.1 RESEARCH DATA 37
2.1.1 SECONDARY DATA 38
- 2.1.1.1 Secondary sources 38
2.1.2 PRIMARY DATA 39
- 2.1.2.1 Key data from primary sources 40
- 2.1.2.2 Key industry insights 41
- 2.1.2.3 Breakdown of primary interviews 41
2.2 MARKET SIZE ESTIMATION 42
2.2.1 APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH 42
2.2.2 APPROACH 2: NUMBER OF PIPETTE CALIBRATORS 43
2.2.3 APPROACH 3: PRESENTATIONS OF COMPANIES AND PRIMARY INTERVIEWS 44
2.2.4 APPROACH 4: PRIMARY INTERVIEWS 44
2.2.5 GROWTH FORECAST 44
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 47
2.4 MARKET SHARE ANALYSIS 48
2.5 MARKET ASSUMPTIONS 48
2.6 RISK ASSESSMENT 48
2.7 RECESSION IMPACT ON PIPETTE CALIBRATORS MARKET 49
3 EXECUTIVE SUMMARY 50
4 PREMIUM INSIGHTS 55
4.1 PIPETTE CALIBRATORS MARKET OVERVIEW 55
4.2 ASIA PACIFIC: PIPETTE CALIBRATORS MARKET, BY TYPE AND COUNTRY (2022) 56
4.3 PIPETTE CALIBRATORS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 57
4.4 PIPETTE CALIBRATORS MARKET: REGIONAL MIX 57
5 MARKET OVERVIEW 58
5.1 MARKET DYNAMICS 58
5.1.1 DRIVERS 59
- 5.1.1.1 Stringent quality standards and regulations 59
- 5.1.1.2 Increasing automation 59
- 5.1.1.3 Expansion of pharmaceutical & biotechnology industries 60
- 5.1.1.4 Growing R&D expenditure by pharmaceutical and biopharmaceutical companies 60
- 5.1.1.5 Increasing focus on data precision and accuracy 61
5.1.2 RESTRAINTS 61
- 5.1.2.1 High pricing of pipette calibration systems 61
- 5.1.2.2 Alternative technologies 61
- 5.1.2.3 Slow adoption of automation in small and mid-sized laboratories 62
5.1.3 OPPORTUNITIES 63
- 5.1.3.1 Changing market scenario in developing countries 63
- 5.1.3.2 Growing genomics and proteomics research 63
5.1.4 CHALLENGES 64
- 5.1.4.1 Underdeveloped infrastructure and lack of talent management in developing countries 64
- 5.1.4.2 Rise in pipette calibration services 65
5.1.5 TRENDS 65
- 5.1.5.1 Adoption of digital and electronic pipettes 65
- 5.1.5.2 Rise of cloud-based calibration management 65
- 5.1.5.3 Portable and handheld calibration devices 66
5.2 VALUE CHAIN ANALYSIS 66
5.3 SUPPLY CHAIN ANALYSIS 67
5.4 PORTER’S FIVE FORCES ANALYSIS 68
5.4.1 THREAT OF NEW ENTRANTS 68
5.4.2 INTENSITY OF COMPETITIVE RIVALRY 68
5.4.3 BARGAINING POWER OF BUYERS 69
5.4.4 BARGAINING POWER OF SUPPLIERS 69
5.4.5 THREAT OF SUBSTITUTES 69
5.5 REGULATORY ANALYSIS 69
5.6 TRADE ANALYSIS 71
5.6.1 TRADE ANALYSIS FOR PIPETTE CALIBRATORS 71
5.7 TECHNOLOGY ANALYSIS 72
5.8 ECOSYSTEM ANALYSIS 72
5.8.1 ROLE IN ECOSYSTEM 73
5.9 PATENT ANALYSIS 75
5.10 KEY CONFERENCES AND EVENTS IN 2024-2025 76
5.11 PRICING ANALYSIS 77
5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 78
5.12.1 REVENUE SHIFT & REVENUE POCKETS FOR PIPETTE CALIBRATOR MANUFACTURERS 78
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 79
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 79
5.13.2 BUYING CRITERIA 80
6 PIPETTE CALIBRATORS MARKET, BY TYPE 81
6.1 INTRODUCTION 82
6.2 DEVICES 82
6.2.1 EXPANSION OF PHARMACEUTICAL AND BIOTECHNOLOGY MANUFACTURING COMPANIES TO DRIVE MARKET 82
6.3 SOFTWARE 85
6.3.1 DESIGNED TO FACILITATE CALIBRATION AND MAINTENANCE OF PIPETTES USED IN LABORATORIES 85
7 PIPETTE CALIBRATORS MARKET, BY CHANNEL TYPE 88
7.1 INTRODUCTION 89
7.2 SINGLE CHANNEL 89
7.2.1 INCREASING ADOPTION IN PHARMACEUTICAL & BIOTECHNOLOGY INDUSTRIES TO DRIVE MARKET 89
7.3 MULTICHANNEL 92
7.3.1 HIGH COST AND DIFFICULT TO MAINTAIN & CALIBRATE- KEY FACTORS RESTRAINING MARKET GROWTH 92
8 PIPETTE CALIBRATORS MARKET, BY METHOD 95
8.1 INTRODUCTION 96
8.2 GRAVIMETRIC 96
8.2.1 WIDESPREAD ACCEPTANCE AND ENDORSEMENT FROM BOTH NATIONAL AND INTERNATIONAL REGULATORY BODIES TO SUPPORT MARKET GROWTH 96
8.3 PHOTOMETRIC 98
8.3.1 SUITABLE FOR APPLICATIONS INVOLVING LOW-VOLUME MEASUREMENTS AND HIGH-THROUGHPUT SCREENING 98
8.4 OTHER METHODS 101
9 PIPETTE CALIBRATORS MARKET, BY APPLICATION 104
9.1 INTRODUCTION 105
9.2 RESEARCH 105
9.2.1 DRUG DISCOVERY 108
- 9.2.1.1 Increasing incidence of chronic diseases to drive market 108
9.2.2 GENOMICS 109
- 9.2.2.1 Increased need to understand human physiology and molecular basis of diseases to support market 109
9.2.3 PROTEOMICS 110
- 9.2.3.1 Growing government investments to support market 110
9.2.4 OTHER RESEARCH APPLICATIONS 111
9.3 CLINICAL DIAGNOSTICS 112
9.3.1 INCREASING NUMBER OF CLINICAL TESTS TO DRIVE MARKET 112
10 PIPETTE CALIBRATORS MARKET, BY END USER 115
10.1 INTRODUCTION 116
10.2 PHARMACEUTICAL & BIOTECHNOLOGY INDUSTRIES 116
10.2.1 RISING FOCUS ON DRUG DISCOVERY TO DRIVE MARKET 116
10.3 HOSPITALS 119
10.3.1 INCREASING NUMBER OF HOSPITALS TO SUPPORT MARKET GROWTH 119
10.4 ACADEMIC & RESEARCH INSTITUTES 122
10.4.1 INCREASED AVAILABILITY OF FUNDING TO DRIVE PURCHASE OF PIPETTE CALIBRATION SYSTEMS 122
11 PIPETTE CALIBRATORS MARKET, BY REGION 125
11.1 INTRODUCTION 126
11.2 NORTH AMERICA 127
11.2.1 NORTH AMERICA: RECESSION IMPACT 130
11.2.2 US 130
- 11.2.2.1 Growth in pharmaceutical & biotechnology industry to drive market 130
11.2.3 CANADA 134
- 11.2.3.1 Strong research base and government support to propel market 134
11.3 EUROPE 137
11.3.1 EUROPE: RECESSION IMPACT 139
11.3.2 GERMANY 140
- 11.3.2.1 Large number of ongoing drug research projects to drive market 140
11.3.3 UK 143
- 11.3.3.1 Rising number of academia-industry partnerships and research activities to drive growth 143
11.3.4 FRANCE 146
- 11.3.4.1 Increasing investments in infrastructure development to drive market growth 146
11.3.5 ITALY 150
- 11.3.5.1 Growing number of biotechnology firms to support market growth 150
11.3.6 SPAIN 153
- 11.3.6.1 Availability of research funds and grants to boost market growth 153
11.3.7 REST OF EUROPE 156
11.4 ASIA PACIFIC 159
11.4.1 ASIA PACIFIC: RECESSION IMPACT 163
11.4.2 CHINA 163
- 11.4.2.1 Increasing investments by companies in innovative drugs to drive market 163
11.4.3 JAPAN 167
- 11.4.3.1 Government initiatives to drive market 167
11.4.4 INDIA 170
- 11.4.4.1 Growing biotech sector and favorable government policies to drive market 170
11.4.5 REST OF ASIA PACIFIC 174
11.5 REST OF THE WORLD 177
11.5.1 REST OF THE WORLD: RECESSION IMPACT 179
11.5.2 LATIN AMERICA 180
- 11.5.2.1 Growing biosimilar investments to drive market growth 180
11.5.3 MIDDLE EAST & AFRICA 183
- 11.5.3.1 High prevalence of chronic conditions to aid market growth 183
11.5.4 GCC COUNTRIES 186
- 11.5.4.1 Rising demand for biopharmaceuticals to propel market 186
12 COMPETITIVE LANDSCAPE 189
12.1 OVERVIEW 189
12.2 STRATEGIES ADOPTED BY KEY PLAYERS 189
12.3 REVENUE ANALYSIS 191
12.4 MARKET SHARE ANALYSIS 191
12.5 BRAND/PRODUCT COMPARISON 192
12.6 COMPANY EVALUATION MATRIX: KEY PLAYERS 193
12.6.1 STARS 193
12.6.2 EMERGING LEADERS 193
12.6.3 PERVASIVE PLAYERS 193
12.6.4 PARTICIPANTS 193
12.6.5 COMPANY FOOTPRINT 195
12.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES 196
12.7.1 PROGRESSIVE COMPANIES 196
12.7.2 STARTING BLOCKS 196
12.7.3 RESPONSIVE COMPANIES 196
12.7.4 DYNAMIC COMPANIES 197
12.7.5 COMPETITIVE BENCHMARKING 198
12.8 COMPETITIVE SCENARIO 200
12.8.1 PRODUCT LAUNCHES 200
12.8.2 DEALS 201
13 COMPANY PROFILES 202
13.1 KEY PLAYERS 202
13.1.1 METTLER TOLEDO 202
13.1.2 SARTORIUS AG 205
13.1.3 A&D COMPANY, LIMITED 208
13.1.4 ADVANCED INSTRUMENTS 211
13.1.5 ACCURIS INSTRUMENTS 213
13.1.6 IKA WORKS GMBH & CO. KG 214
13.1.7 RADWAG BALANCES AND SCALES 215
13.1.8 AVANTOR, INC 216
13.1.9 BIOHIT OYJ 218
13.1.10 CALIBRATION LAB 220
13.1.11 BRAND GMBH + CO KG 221
13.2 OTHER PLAYERS 222
13.2.1 PRIME TECHNOLOGIES 222
13.2.2 BIOMEDICAL COMPUTING LTD 222
13.2.3 COLE-PARMER INSTRUMENT COMPANY, LLC 223
13.2.4 HUMPAGE TECHNOLOGY LTD 223
13.2.5 IBR INC 224
13.2.6 SARTORIUS CROATIA 224
13.2.7 GILSON INCORPORATED 225
13.2.8 LABTRONICS INC 225
13.2.9 TECHVOLVER APS 226
14 APPENDIX 227
14.1 DISCUSSION GUIDE 227
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 231
14.3 CUSTOMIZATION OPTIONS 233
14.4 RELATED REPORTS 233
14.5 AUTHOR DETAILS 234